Compare conditions

Put any two — or three — conditions side by side, adult or pediatric, to spot the look-alike differences fast, row by row.

Blood thinners

—

In one line

·Blood thinners slow down clotting by blocking specific proteins in the clotting chain, preventing dangerous clots but raising the risk of bleeding.

—

Normal physiology

·The clotting system (hemostasis) has two main parts: platelets (tiny cell fragments that stick together to plug holes in blood vessels) and the coagulation cascade (a chain reaction of proteins that weave a strong mesh called fibrin to lock the clot in place). Key players in this chain are Factor Xa (the tenth protein) and thrombin (also called Factor IIa, the enzyme that cuts fibrinogen into fibrin strands). Several clotting proteins (Factors II, VII, IX, X) need vitamin K to be made in the liver. Blood thinners work by blocking one or more steps in this chain.

—

What goes wrong

·The core problem is walking a tightrope: the blood thinner dose that prevents clots is close to the dose that causes dangerous bleeding. Too much medicine and the clotting chain is blocked so hard that even tiny leaks cannot seal—you bleed. Too little and the chain still runs—you clot. Changes in kidney function, liver function, other medicines, or missed doses tip you off the rope in either direction.

—

Hallmark signs

·Nosebleeds that start easily or last longer than usual
·Bleeding gums when you brush your teeth or eat
·Bruises from light bumps, or tiny red or purple dots on the skin
·Pink, red, or cola-colored urine
·Black, sticky stool (like tar) or bright-red blood in stool
·Vomiting blood—either bright red or dark like coffee grounds
·Sudden severe headache, confusion, slurred speech, or one-sided weakness
·Heart racing (over 100 beats per minute) or blood pressure dropping (top number under 90)

—

Red flags · escalate now

·Bleeding inside the skull: sudden severe headache, confusion, weakness on one side, trouble speaking, seizure, or passing out
·Shock from blood loss: top blood pressure under 90, heart rate over 120, pale and sweaty skin, confusion, or feeling faint
·Massive bleeding from the digestive tract: vomiting blood, large amounts of black tarry stool or red blood in stool, signs of shock
·Bleeding inside the eye: sudden vision loss, a curtain or shadow over part of your vision, or eye pain
·New clot despite being on a blood thinner: new leg swelling and pain (DVT), new trouble breathing and chest pain (PE), or stroke symptoms—suggests the dose is too low or the medicine isn't working

—

Workup

·INR (international normalized ratio)—for patients taking warfarin
·Anti-Xa level—for DOACs (direct oral anticoagulants: apixaban, rivaroxaban, edoxaban) and LMWH (low-molecular-weight heparin: enoxaparin, dalteparin)
·Serum creatinine and eGFR (estimated glomerular filtration rate)
·Complete blood count (CBC) with hemoglobin, hematocrit, and platelet count
·CT head without contrast—for any patient with severe headache, confusion, or focal neurologic signs (weakness, numbness, vision change)
·aPTT (activated partial thromboplastin time)—for patients on unfractionated heparin IV drip
·Liver function tests (ALT, AST, bilirubin, INR)—especially in patients on warfarin or with known liver disease

—

Treatment

·For major or life-threatening bleeding on warfarin: give vitamin K (5–10 mg IV slowly) PLUS 4-factor prothrombin complex concentrate (PCC, 25–50 units/kg IV) together immediately
·For major bleeding on dabigatran (Pradaxa): give idarucizumab (Praxbind, 5 grams IV as two 2.5 g doses 15 minutes apart)
·For major bleeding on apixaban (Eliquis) or rivaroxaban (Xarelto): give andexanet alfa (Andexxa) per FDA dosing protocol, or 4-factor PCC (50 units/kg IV) if andexanet is unavailable
·For bleeding on LMWH (enoxaparin, dalteparin) or fondaparinux: give protamine sulfate (1 mg per 100 units of heparin or 1 mg per 1 mg enoxaparin, maximum 50 mg IV slowly over 10 minutes)
·Check serum creatinine and eGFR immediately in any patient with bleeding on a blood thinner
·Hold the next scheduled dose of anticoagulant and perform a head-to-toe bleeding assessment: check nose, gums, skin (for bruises and pinpoint bleeding spots (petechiae)), urine color, stool color, and neurologic status (alertness, speech, strength, coordination)
·Review the medication list and adherence carefully: look for drug interactions (NSAIDs like ibuprofen, antiplatelet agents like aspirin or clopidogrel, antibiotics like ciprofloxacin or azithromycin, antifungals like fluconazole), missed or extra doses, herbal supplements (ginkgo, garlic, ginger, turmeric), and alcohol use

—

NCLEX trap

·Do not stop the blood thinner suddenly. The patient needs it to prevent deadly clots—heart attacks, strokes, and pulmonary embolism (a clot lodging in a lung artery) (a clot blocking the artery feeding the lungs). Instead, reverse the blood thinner effect with vitamin K plus four-factor prothrombin complex concentrate (4F-PCC—a medicine that replaces four clotting proteins instantly) for major bleeding, or vitamin K alone if the blood test (INR) is too high but there is no bleeding yet. Once bleeding stops, restart the blood thinner at a lower, safer dose.
·Vitamin K alone takes 12 to 24 hours to bring the INR (a blood test showing how thin the blood is) down. For life-threatening bleeding—brain bleed, stomach or intestine bleed, or shock from blood loss—give 4F-PCC right now. It reverses warfarin in 15 minutes by replacing the clotting proteins the body needs. Then give vitamin K (5 to 10 mg through the IV) to keep the INR down over the next day or two. This is the standard from the American College of Chest Physicians and American Society of Hematology.
·DOACs (direct oral anticoagulants—blood thinners that block one specific clotting protein) do not respond to vitamin K at all. For dabigatran (Pradaxa), use idarucizumab (Praxbind—the antidote made just for dabigatran). For apixaban (Eliquis) or rivaroxaban (Xarelto), use andexanet alfa (Andexxa) first, or 4F-PCC if andexanet is not available. Vitamin K only works for warfarin because warfarin blocks proteins that need vitamin K to work. Match the reversal agent to the specific blood thinner the patient is taking.
·A new clot while on a blood thinner means the dose is too low, not that the medicine failed. Check the blood test—INR for warfarin, anti-Xa level for apixaban or rivaroxaban, or aPTT (a clotting test) for heparin. Increase the dose to reach the protective range. Stopping the blood thinner will cause more clots. The problem is the dose is not strong enough—fix it by raising the dose or switching to a different blood thinner, never by stopping treatment.
·Check these blood tests regularly to catch problems before bleeding or clots happen. For warfarin, check INR 2 to 3 days after starting, then every few days until it stays in the safe range (usually 2 to 3), then every 4 weeks. For DOACs, check kidney function (blood tests showing how well the kidneys work) at the start and every 6 to 12 months, because kidneys clear these drugs from the body. Check anti-Xa or drug levels if the patient has sudden kidney injury, major bleeding, needs emergency surgery, or takes a new drug that interferes. Finding a too-high or too-low level early prevents bleeding or clots.
·Blood thinners leave the body through the kidneys. If kidney function drops, the blood thinner builds up and bleeding risk shoots up. Doses must be lowered for patients with chronic kidney disease or adjusted based on creatinine clearance (CrCl—a number showing how fast kidneys filter waste). For example, apixaban dose drops from 5 mg twice a day to 2.5 mg twice a day if CrCl is 15 to 29, or if the patient meets two of these three: age 80 or older, weight 60 kg or less, or creatinine 1.5 or higher. Dabigatran should not be used at all if CrCl is under 30. Always calculate CrCl with the Cockcroft-Gault equation and adjust the dose per FDA labeling and current guidelines.

—

Install Maldek by Hill as an app — studies work even offline